Achieve Stock Today

ACHV
 Stock
  

USD 2.75  0.05  1.79%   

Market Performance
0 of 100
Odds Of Distress
Less than 42
Achieve Life is selling for under 2.75 as of the 4th of December 2022; that is -1.79 percent down since the beginning of the trading day. The stock's lowest day price was 2.72. Achieve Life has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Achieve Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of November 2021 and ending today, the 4th of December 2022. Click here to learn more.
CUSIP
835692104
Fiscal Year End
December
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
13th of October 1995
Category
Healthcare
Classification
Health Care
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. The company has 17.9 M outstanding shares of which 334.05 K shares are presently shorted by private and institutional investors with about 5.07 trading days to cover. More on Achieve Life Sciences

Moving together with Achieve Life

+0.83BEAMBeam TherapeuticsInc Normal TradingPairCorr

Moving against Achieve Life

-0.64CATCaterpillar TrendingPairCorr
-0.56JPMJPMorgan Chase Fiscal Year End 13th of January 2023 PairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Achieve Life Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Achieve Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Achieve Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Achieve Life generated a negative expected return over the last 90 days
Achieve Life has high historical volatility and very poor performance
Net Loss for the year was (33.15 M) with profit before overhead, payroll, taxes, and interest of 0.
Achieve Life Sciences currently holds about 29.38 M in cash with (29.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Achieve Life has a frail financial position based on the latest SEC disclosures
Roughly 15.0% of the company shares are held by company insiders
Latest headline from news.google.com: Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates and Plans for 150 Million Share Repurchase - Marketscreener.com
Chairman of the Board, CEORichard Stewart
Fama & French Classification
Average Analyst Recommendation
Analysts covering Achieve Life report their recommendations after researching Achieve Life's financial statements, talking to executives and customers, or listening in on Achieve Life's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Achieve Life Sciences. The Achieve consensus assessment is calculated by taking the average forecast from all of the analysts covering Achieve Life.
Strong Buy5 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Achieve Life Sciences based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Achieve Life Sciences financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted1.9 M2.5 M
Significantly Down
Increasing
Slightly volatile
Weighted Average Shares1.9 M2.5 M
Significantly Down
Increasing
Slightly volatile
Current Liabilities10 M9.7 M
Fairly Up
Decreasing
Slightly volatile
Total Liabilities10 M9.8 M
Fairly Up
Decreasing
Slightly volatile
Gross Margin0.890.9
Fairly Down
Decreasing
Slightly volatile
Total Debt16.2 M15 M
Significantly Up
Increasing
Stable
Asset Turnover0.110.11
Steady
Decreasing
Slightly volatile
Current Assets31.8 M31 M
Fairly Up
Decreasing
Slightly volatile
Total Assets32.4 M31.6 M
Fairly Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Achieve Life's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Financial Strength
Achieve Life's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Achieve Life's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Achieve Life's financial leverage. It provides some insight into what part of Achieve Life's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Achieve Life's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Achieve Life deploys its capital and how much of that capital is borrowed.
Liquidity
Achieve Life cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 14.92 M in liabilities with Debt to Equity (D/E) ratio of 1.18, which is about average as compared to similar companies. Achieve Life Sciences has a current ratio of 5.69, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Achieve Life until it has trouble settling it off, either with new capital or with free cash flow. So, Achieve Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Achieve Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Achieve to invest in growth at high rates of return. When we think about Achieve Life's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(28.82 Million)
Achieve Life Sciences (ACHV) is traded on NASDAQ Exchange in USA and employs 16 people. Achieve Life is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 49.57 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Achieve Life's market, we take the total number of its shares issued and multiply it by Achieve Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Achieve Life Sciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 17.9 M outstanding shares of which 334.05 K shares are presently shorted by private and institutional investors with about 5.07 trading days to cover. Achieve Life Sciences currently holds about 29.38 M in cash with (29.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Achieve Life Probability Of Bankruptcy
Ownership
Achieve Life holds a total of seventeen million eight hundred ninety-seven thousand outstanding shares. Achieve Life Sciences shows significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Achieve Life Sciences stock in recent months. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Achieve Ownership Details

Achieve Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of Achieve Life jumping above the current price in 90 days from now is about 66.29%. The Achieve Life Sciences probability density function shows the probability of Achieve Life stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Achieve Life has a beta of 0.8246. This suggests as returns on the market go up, Achieve Life average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Achieve Life Sciences will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Achieve Life Sciences is significantly underperforming NYSE Composite.
  Odds Below 2.75HorizonTargetOdds Above 2.75
33.63%90 days
 2.75 
66.29%
Based on a normal probability distribution, the odds of Achieve Life to move above the current price in 90 days from now is about 66.29 (This Achieve Life Sciences probability density function shows the probability of Achieve Stock to fall within a particular range of prices over 90 days) .

Achieve Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Achieve Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Achieve Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Achieve Life's value.
InstituionSecurity TypeTotal SharesValue
Worth Venture Partners LlcCommon Shares14.3 K24 K
Worth Venture Partners LlcCommon Shares71.8 K139 K
View Achieve Life Diagnostics

Achieve Life Historical Income Statement

Achieve Life Sciences Income Statement is one of the three primary financial statements used for reporting Achieve's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Achieve Life Sciences revenue and expense. Achieve Life Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Achieve Life Gross Profit is fairly stable at the moment as compared to the past year. Achieve Life reported Gross Profit of 20.88 Million in 2021. Revenues is likely to climb to about 4.7 M in 2022, whereas Consolidated Income is likely to drop (35.8 M) in 2022. View More Fundamentals

Achieve Stock Against Markets

Picking the right benchmark for Achieve Life stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Achieve Life stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Achieve Life is critical whether you are bullish or bearish towards Achieve Life Sciences at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Achieve Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Achieve Life Corporate Directors

Achieve Life corporate directors refer to members of an Achieve Life board of directors. The board of directors generally takes responsibility for the Achieve Life's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Achieve Life's board members must vote for the resolution. The Achieve Life board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Scott Cormack - Independent DirectorProfile
Martin Mattingly - Independent DirectorProfile
Donald Joseph - DirectorProfile
Stewart Parker - Independent DirectorProfile

Invested in Achieve Life Sciences?

The danger of trading Achieve Life Sciences is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Achieve Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Achieve Life. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Achieve Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Achieve Life Sciences information on this page should be used as a complementary analysis to other Achieve Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Achieve Stock analysis

When running Achieve Life Sciences price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Achieve Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achieve Life. If investors know Achieve will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achieve Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
49.6 M
Return On Assets
(0.75) 
Return On Equity
(2.14) 
The market value of Achieve Life Sciences is measured differently than its book value, which is the value of Achieve that is recorded on the company's balance sheet. Investors also form their own opinion of Achieve Life's value that differs from its market value or its book value, called intrinsic value, which is Achieve Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achieve Life's market value can be influenced by many factors that don't directly affect Achieve Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achieve Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Achieve Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achieve Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.